Fluid resuscitation attenuates early cytokine mRNA expression after peritonitis

Journal of Trauma - Injury, Infection and Critical Care

Volumn 41, Issue 4, 1996, Pages 622-627

  Wilson, Mark A ^a   Chou, Maria C ^b   Spain, David A ^b   Downard, Patrick J ^b   Qian, Qinghua ^b   Cheadle, William G ^b   Garrison, R Neal ^b  

^a University of Louisville School of Medicine   (United States)

^b NONE

Author keywords

Cecal ligation and puncture; Fluid resuscitation; Interleukin 1; Liver; Peritonitis; Small intestine; Tumor necrosis factor

Indexed keywords

CYTOKINE; INTERLEUKIN 1BETA; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; MALE; MOUSE; NONHUMAN; PERITONITIS; PRIORITY JOURNAL; RESUSCITATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; SURVIVAL;

EID: 0029998070     PISSN: 00225282     EISSN: 15298809     Source Type: Journal    
DOI: 10.1097/00005373-199610000-00005     Document Type: Article

References (28)

1. Tracey KJ, Fong Y, Hesse DG, et al: Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature 330:662, 1987
2. Anderson JA, Knott AW, Wilson MA, et al: The effect of soluble tumor necrosis factor receptor-II on endotoxin-mediated hemodynamic instability. J Surg Res 58:53, 1995
3. Swuadrito F, Atavilla D, Ioculano M, et al: Passive immunization with antibodies against tumor necrosis factor (TNF-α) protects from the lethality of splanchnic artery occlusion shock. Circ Shock 37:236, 1992
4. Emerson TE Jr, Lindsey C, Jesmok GJ, et al: Efficacy of monoclonal antibody against tumor necrosis factor alpha in an endotoxemic baboon model. Circ Shock 28:75, 1992
5. Alexander HR, Doherty GM, Venzon DJ, et al: Recombinant interleukin-1 receptor antagonist (IL-1ra): Effective therapy against gram-negative sepsis in rats. Surgery 112:188, 1992
6. Polk HC Jr, Cheadle WG, Livingston DH, et al: A randomized prospective clinical trial to determine the efficacy of interferon-γ in severely injured patients. Am J Surg 163:191, 1992
7. Ziegler EJ, Fisher CJ, Sprung CL, et al: Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. N Engl J Med 324:429, 1991
8. Greenman RL, Schein RMH, Hartin MA, et al: A controlled clinical trial of E5 murine monoclonal IgM antibody to endotoxin in the treatment of gram-negative sepsis. JAMA 266:1097, 1991
9. Smith EF III, Slivjak MJ, Egan JW, et al: Fluid resuscitation improves survival of endotoxemic or septicemic rats: Possible contribution of tumor necrosis factor. Pharmacology 46:254, 1993
10. Wang P, Zhou M, Rana MA, et al: Differential alterations in microvascular perfusion in various organs during early and late sepsis. Am J Physiol 263:G38, 1992
11. Wichterman KA, Baue AE. Chaudry IH: Sepsis and septic-shock: A review of laboratory models and a proposal. J Surg Res 29:189, 1980
12. McMasters KM, Cheadle WG: Regulation of macrophage TNF-α, IL-1β, and Ia (I-Aα) mRNA expression during peritonitis is site dependent. J Surg Res 54:426, 1993
13. Hadjiminas DJ, McMasters KM, Peyton JC, et al: Passive immunization against tumor necrosis factor and interleukin-1 fails to reduce lung neutrophil sequestration in chronic sepsis. Shock 2:376, 1994
14. Hadjiminas DJ, McMasters KM, Peyton JC, et al: Tissue tumor necrosis factor mRNA expression following cecal ligation and puncture or intraperitoneal injection of endotoxin. J Surg Res 56:549, 1994
15. Chromczynski P, Sacchi N: Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156, 1987
16. Dinarello C: The biology of interleukin-1. Chem Immunol 51:1, 1992
17. Keogh C, Fong Y, Marano MA, et al: Identification of a novel tumor necrosis factor/cachectin from the livers of burned infected rats. Arch Surg 125:79, 1990
18. Scales WE, Chensue SW, Otterness I: Regulation of monokine gene expression: Prostaglandin E, suppresses tumor necrosis factor but not interleukin-1α or β-mRNA and cell-associated bioactivity. J Leukoc Biol 45:416, 1989
19. Dong Z, Lu S, Zhang Y: Effects of pretreatment with protein kinase C activators on macrophage activation for tumor cytotoxicity, secretion of tumor necrosis factor, and its mRNA expression. Immunobiology 179:382, 1989
20. Oswald IP, Wynn TA, Sher A, et al: Interleukin 10 inhibits macrophage microbicidal activity by blocking the endogenous production of tumor necrosis factor α required as a costimulatory factor for interferon γ-induced activation. Pror Natl Acad Sci U S A 89:8676, 1992
21. Frye RA, Benz CC, Liu E: Detection of amplified oncogenes by differential polymerase chain reaction. Oncogene 4:1153, 1989
22. Neubauer A, Neubauer B, Liu E, et al: Polymerase reaction based assay to detect allelic loss in human DNA: Loss of γ-interferon gene in chronic myelogenous leukemia. Nucleic Acids Res 18:993, 1990
23. Bone RC: The pathogenesis of sepsis. Ann Intern Med 115:457, 1991
24. Damas P, Reuter A, Gysen P: Tumor necrosis factor and interleukin-1 serum levels during severe sepsis in humans. Crit Care Med 17:975, 1989
25. Marano MA, Fong Y, Molawer LL, et al: Serum cachectin/ tumor necrosis factor in critically ill patients with burns correlates with infection and mortality. Surg Gynecol Obstet 170:32, 1990
26. McMasters KM, Peyton JC, Hadjiminas DJ, et al: Endotoxin and tumour necrosis factor do not cause mortality from cecal ligation and puncture. Cytokine 6:530, 1994
27. Carroll GC, Snyder JV: Hyperdynamic severe intravascular sepsis depends on fluid administration in cynomolgus monkey. Am J Physiol 243:R131, 1982
28. Ottoson J, Dawidson I, Brandberg A, et al: Cardiac output and organ blood flow in experimental septic shock: Effect of treatment with antibiotics, corticosteroids, and fluid infusion. Circ Shock 35:14, 1991